Saxitoxin (STX), produced by certain harmful algal bloom (HAB) species, bioaccumulates through the food chain and can cause paralytic toxicity in humans, potentially resulting in fatal outcomes. To date, STX detection has primarily been conducted under laboratory-controlled conditions, and the availability of a gold-standard method for the proactive monitoring and prevention of HAB-induced secondary damage remains limited. Therefore, the present study introduces an electrochemical-based biosensor that is capable of early monitoring of STX in HAB-occurred environments. The conserved region of sxtA4, a nucleic acid precursor that is essential for STX biosynthesis, is immobilized on the sensing membrane surface in a sandwich structure. In this process, target detection is recognized as an electrochemical signal by a methylene blue-labeled detection probe, and the reliability of biosensing is supplemented by an electrochemical trend that is opposite to DNA binding. The application of an alternating current electrochemical flow technique achieves more sensitive detection at attomolar levels and rapid measurement within 10 min than a conventional DNA biosensor based on hybridization. In addition, the designed biosensing structure selectively detects STX-synthesizing and non-synthesizing dinoflagellates significantly. The proposed platform can utilize the identification of STX-induced secondary damage of HAB and provide insight into a field-ready biosensor based on its characterization and detection performance.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: